Variant report

Variant	esv3415262
Chromosome Location	chr2:114333882-114342080
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:846)
CpG islands
(count:306)
Chromatin interactive
region (count:0)
LncRNA
region (count:15)
Mature miRNA
region (count: 1)
miRNA target
sites (count:0)

(count:846 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:114341464-114341790	HepG2	liver:	n/a	n/a
2	ARID3A	chr2:114341528-114341709	K562	blood:	n/a	n/a
3	ARID3A	chr2:114340115-114340374	K562	blood:	n/a	n/a
4	ATF1	chr2:114340089-114340480	K562	blood:	n/a	n/a
5	ATF2	chr2:114341413-114341806	GM12878	blood:	n/a	n/a
6	ATF2	chr2:114341425-114341694	H1-hESC	embryonic stem cell:	n/a	n/a
7	ATF3	chr2:114341420-114341810	A549	lung:	n/a	n/a
8	ATF3	chr2:114341426-114341722	A549	lung:	n/a	n/a
9	BATF	chr2:114341927-114342368	GM12878	blood:	n/a	n/a
10	BATF	chr2:114340809-114341094	GM12878	blood:	n/a	n/a
11	BATF	chr2:114341254-114341925	GM12878	blood:	n/a	n/a
12	BATF	chr2:114340791-114341141	GM12878	blood:	n/a	n/a
13	BATF	chr2:114337655-114337855	GM12878	blood:	n/a	n/a
14	BCL11A	chr2:114338132-114338304	GM12878	blood:	n/a	n/a
15	BCL11A	chr2:114341161-114342683	GM12878	blood:	n/a	chr2:114341890-114341903 chr2:114341855-114341868 chr2:114341592-114341601 chr2:114341601-114341614 chr2:114341854-114341867
16	BCL11A	chr2:114340779-114341050	GM12878	blood:	n/a	n/a
17	BCL11A	chr2:114341277-114342392	GM12878	blood:	n/a	chr2:114341890-114341903 chr2:114341855-114341868 chr2:114341592-114341601 chr2:114341601-114341614 chr2:114341854-114341867
18	BCLAF1	chr2:114341440-114341761	GM12878	blood:	n/a	chr2:114341592-114341601 chr2:114341601-114341614
19	BCLAF1	chr2:114341405-114341749	K562	blood:	n/a	chr2:114341592-114341601 chr2:114341601-114341614
20	BCLAF1	chr2:114341433-114341804	GM12878	blood:	n/a	chr2:114341592-114341601 chr2:114341601-114341614
21	BCLAF1	chr2:114341410-114341746	K562	blood:	n/a	chr2:114341592-114341601 chr2:114341601-114341614
22	BHLHE40	chr2:114341439-114341796	GM12878	blood:	n/a	n/a
23	BHLHE40	chr2:114341023-114342085	HepG2	liver:	n/a	n/a
24	BHLHE40	chr2:114337717-114338231	HepG2	liver:	n/a	n/a
25	BHLHE40	chr2:114339443-114339717	HepG2	liver:	n/a	n/a
26	BHLHE40	chr2:114341424-114341790	K562	blood:	n/a	n/a
27	BHLHE40	chr2:114341416-114341782	HepG2	liver:	n/a	n/a
28	BRCA1	chr2:114341592-114341723	HepG2	liver:	n/a	n/a
29	CBX3	chr2:114341256-114342113	K562	blood:	n/a	n/a
30	CBX3	chr2:114341274-114341768	K562	blood:	n/a	n/a
31	CBX3	chr2:114337593-114339002	K562	blood:	n/a	n/a
32	CBX3	chr2:114335770-114336797	K562	blood:	n/a	n/a
33	CBX3	chr2:114337671-114338800	K562	blood:	n/a	n/a
34	CBX3	chr2:114341495-114341746	HCT-116	colon:	n/a	n/a
35	CBX3	chr2:114334040-114334625	K562	blood:	n/a	n/a
36	CBX3	chr2:114339835-114341137	K562	blood:	n/a	n/a
37	CCNT2	chr2:114341529-114341828	K562	blood:	n/a	n/a
38	CEBPB	chr2:114341209-114341949	GM12878	blood:	n/a	n/a
39	CEBPB	chr2:114341488-114341742	GM12878	blood:	n/a	n/a
40	CEBPB	chr2:114337775-114337980	IMR90	lung:	n/a	n/a
41	CEBPB	chr2:114341538-114341725	Hela-S3	cervix:	n/a	n/a
42	CEBPB	chr2:114334095-114334557	K562	blood:	n/a	n/a
43	CEBPB	chr2:114337607-114338681	K562	blood:	n/a	n/a
44	CEBPB	chr2:114337659-114337982	K562	blood:	n/a	n/a
45	CEBPB	chr2:114341492-114341684	HepG2	liver:	n/a	n/a
46	CEBPB	chr2:114341529-114341724	H1-hESC	embryonic stem cell:	n/a	n/a
47	CEBPB	chr2:114341433-114341712	HepG2	liver:	n/a	n/a
48	CEBPD	chr2:114341332-114341779	K562	blood:	n/a	n/a
49	CEBPD	chr2:114341452-114341767	HepG2	liver:	n/a	n/a
50	CEBPD	chr2:114333969-114334623	K562	blood:	n/a	n/a

(count:306 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:114334065-114334115	HPAEpiC	pulmonary alveolar:	n/a
2	chr2:114334065-114334115	HPAEpiC	pulmonary alveolar:	n/a
3	chr2:114340391-114340441	AG09319	gingival:	n/a
4	chr2:114341680-114341730	HCM	heart:	n/a
5	chr2:114340391-114340441	Caco-2	colon:	n/a
6	chr2:114341631-114341681	SK-N-SH_RA	brain:	n/a
7	chr2:114340391-114340441	HCT-116	colon:	n/a
8	chr2:114334065-114334115	PFSK-1	brain:	n/a
9	chr2:114340391-114340441	HAEpiC	amniotic membrane:	n/a
10	chr2:114341111-114341161	HEK293	kidney:	embryo
11	chr2:114334065-114334115	HRCEpiC	kidney:	n/a
12	chr2:114341111-114341161	SK-N-MC	brain:	n/a
13	chr2:114341631-114341681	SK-N-MC	brain:	n/a
14	chr2:114341631-114341681	HRCEpiC	kidney:	n/a
15	chr2:114340391-114340441	GM12892	blood:	n/a
16	chr2:114341680-114341730	HCT-116	colon:	n/a
17	chr2:114341631-114341681	ProgFib	skin:	n/a
18	chr2:114340391-114340441	A549	lung:	n/a
19	chr2:114340391-114340441	HRPEpiC	eye:	n/a
20	chr2:114334065-114334115	HNPCEpiC	eye:	n/a
21	chr2:114340391-114340441	GM19239	blood:	n/a
22	chr2:114341680-114341730	Hepatocyte	liver:	n/a
23	chr2:114341680-114341730	ECC-1	luminal epithelium:	n/a
24	chr2:114340391-114340441	NT2-D1	testis:	n/a
25	chr2:114341111-114341161	IMR90	lung:	fetal
26	chr2:114341680-114341730	SKMC	muscle:	n/a
27	chr2:114341631-114341681	NHDF-neo	bronchial:	n/a
28	chr2:114341111-114341161	AG04450	lung:	fetal
29	chr2:114341631-114341681	HCM	heart:	n/a
30	chr2:114341631-114341681	AG10803	skin:	n/a
31	chr2:114341680-114341730	AG04450	lung:	fetal
32	chr2:114341680-114341730	BJ	skin:	n/a
33	chr2:114341111-114341161	MCF-7	breast:	n/a
34	chr2:114341680-114341730	NHBE	bronchial:	n/a
35	chr2:114341631-114341681	HepG2	liver:	n/a
36	chr2:114340391-114340441	AG10803	skin:	n/a
37	chr2:114341631-114341681	Caco-2	colon:	n/a
38	chr2:114340391-114340441	SK-N-MC	brain:	n/a
39	chr2:114341111-114341161	PANC-1	pancreas:	n/a
40	chr2:114334065-114334115	GM12892	blood:	n/a
41	chr2:114341111-114341161	MCF10A-Er-Src	breast:	n/a
42	chr2:114341111-114341161	SAEC	small airway:	n/a
43	chr2:114341631-114341681	HIPEpiC	eye:	n/a
44	chr2:114334065-114334115	A549	lung:	n/a
45	chr2:114341111-114341161	GM12891	blood:	n/a
46	chr2:114334065-114334115	LNCaP	prostate:	n/a
47	chr2:114341680-114341730	GM06990	blood:	n/a
48	chr2:114334065-114334115	SK-N-SH	brain:	n/a
49	chr2:114334065-114334115	AG04450	lung:	fetal
50	chr2:114341631-114341681	HEK293	kidney:	embryo

No data

(count:15 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RABL2A-2	chr2:114335866-114336353	ENSG00000226516
2	lnc-RABL2A-2	chr2:114335559-114336429	ENSG00000226516.3
3	lnc-RABL2A-2	chr2:114334959-114335319	XLOC_001632
4	lnc-AC016745.1-6	chr2:114335509-114335609	l_1930_chr2:114303057-114317403_testes
5	lnc-RABL2A-2	chr2:114335866-114336428	XLOC_001632
6	lnc-RABL2A-2	chr2:114334959-114335319	XLOC_001632
7	lnc-RABL2A-2	chr2:114335192-114335319	ENSG00000226516
8	lnc-RABL2A-2	chr2:114336158-114336486	XLOC_001632
9	lnc-RABL2A-2	chr2:114334959-114335319	ENSG00000226516.3
10	lnc-RABL2A-2	chr2:114335866-114336429	ENSG00000226516.3
11	lnc-RABL2A-2	chr2:114335559-114335961	XLOC_001632
12	lnc-RABL2A-2	chr2:114335559-114335763	ENSG00000226516.3
13	lnc-RABL2A-2	chr2:114335559-114335763	ENSG00000226516
14	lnc-RABL2A-2	chr2:114334959-114335319	ENSG00000226516.3
15	lnc-RABL2A-2	chr2:114335559-114335763	XLOC_001632

miRNA name	Chromosome Location	mirBase accession
hsa-miR-1302	chr2:114340581-114340601	MIMAT0005890_4

No data

Variant related genes	Relation type
WASH2P	TF binding region
MIR1302-3	TF binding region
FAM138B	TF binding region
WASH2P	CpG island
MIR1302-3	CpG island
FAM138B	CpG island
C11orf54	miRNA target sites
C11orf41	miRNA target sites
C10orf88	miRNA target sites

Extended variants
information (count: 301 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:301 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs570563620	chr2:114333893-114333894	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs539565596	chr2:114333935-114333936	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs2758047	chr2:114333948-114333949	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs141686911	chr2:114333950-114333951	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs10864917	chr2:114333971-114333972	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs573418239	chr2:114334044-114334045	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs6727150	chr2:114334048-114334049	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs542132748	chr2:114334060-114334061	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs6740116	chr2:114334066-114334067	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs2441627	chr2:114334075-114334076	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs556069165	chr2:114334080-114334081	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs149457858	chr2:114334083-114334084	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs6730337	chr2:114334102-114334103	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs2441626	chr2:114334106-114334107	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs185880806	chr2:114334108-114334109	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs6712386	chr2:114334109-114334110	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs564076404	chr2:114334110-114334111	Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs533033721	chr2:114334126-114334127	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs148417821	chr2:114334147-114334148	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs56326313	chr2:114334161-114334162	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs415337	chr2:114334175-114334176	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs455157	chr2:114334189-114334190	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs10864918	chr2:114334190-114334191	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs2441625	chr2:114334195-114334196	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs141145756	chr2:114334207-114334208	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs10864919	chr2:114334215-114334216	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs6730472	chr2:114334216-114334217	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs560077304	chr2:114334225-114334226	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs191869042	chr2:114334231-114334232	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs549004590	chr2:114334264-114334265	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs6715502	chr2:114334272-114334273	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs6743126	chr2:114334275-114334276	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs2418670	chr2:114334305-114334306	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs147518320	chr2:114334361-114334362	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs113533434	chr2:114334416-114334417	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs531511745	chr2:114334430-114334431	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs550532272	chr2:114334436-114334437	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs570526827	chr2:114334451-114334452	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs144608812	chr2:114334501-114334502	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs62159309	chr2:114334502-114334503	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs555375705	chr2:114334532-114334533	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs539530887	chr2:114334624-114334625	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs553078360	chr2:114334674-114334675	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs368270240	chr2:114334693-114334694	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs55921705	chr2:114334728-114334729	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs566947055	chr2:114334804-114334805	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs536084832	chr2:114334828-114334829	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs555690331	chr2:114334981-114334982	Enhancers Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
49	rs372907133	chr2:114335131-114335132	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
50	rs200196661	chr2:114335258-114335259	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Colorectal cancer	16912164	CNVD
Ischaemic stroke	16980335	CNVD
Acute myeloid leukemia	18000384	CNVD
Nephronophthisis	17901113	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Myelofibrosis	22110671	CNVD

Chromatin state (count:342 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:114311400-114340400	Weak transcription	Fetal Stomach	stomach
2	chr2:114314600-114339000	Weak transcription	NHLF	lung
3	chr2:114329600-114341000	Weak transcription	NHDF-Ad	bronchial
4	chr2:114330600-114334400	Enhancers	K562	blood
5	chr2:114333200-114334000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
6	chr2:114333200-114340000	Weak transcription	Monocytes-CD14+_RO01746	blood
7	chr2:114333200-114340200	Weak transcription	Primary monocytes fromperipheralblood	blood
8	chr2:114334000-114335000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
9	chr2:114334200-114334800	Enhancers	Fetal Muscle Leg	muscle
10	chr2:114334400-114336600	Weak transcription	K562	blood
11	chr2:114334800-114340200	Weak transcription	Fetal Muscle Leg	muscle
12	chr2:114335000-114336600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr2:114336600-114336800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
14	chr2:114336600-114337000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr2:114336600-114337000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr2:114336600-114340200	Enhancers	K562	blood
17	chr2:114336800-114340200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr2:114337000-114338600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr2:114337000-114340200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr2:114338600-114339000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
21	chr2:114339000-114339200	Enhancers	NHLF	lung
22	chr2:114339000-114340200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr2:114339200-114340200	Weak transcription	NHLF	lung
24	chr2:114340000-114340200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr2:114340000-114340200	Active TSS	Breast Myoepithelial Primary Cells	Breast
26	chr2:114340000-114340200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
27	chr2:114340000-114340200	Enhancers	Fetal Kidney	kidney
28	chr2:114340000-114340200	Enhancers	Dnd41	blood
29	chr2:114340000-114340600	Bivalent Enhancer	HepG2	liver
30	chr2:114340000-114340800	Enhancers	Monocytes-CD14+_RO01746	blood
31	chr2:114340000-114341000	Enhancers	Duodenum Smooth Muscle	Duodenum
32	chr2:114340000-114341000	Enhancers	Fetal Muscle Trunk	muscle
33	chr2:114340000-114341000	Enhancers	Placenta	Placenta
34	chr2:114340000-114341000	Enhancers	HSMMtube	muscle
35	chr2:114340000-114341200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
36	chr2:114340200-114340400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
37	chr2:114340200-114340400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
38	chr2:114340200-114340400	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
39	chr2:114340200-114340400	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
40	chr2:114340200-114340400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr2:114340200-114340400	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
42	chr2:114340200-114340400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr2:114340200-114340400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
44	chr2:114340200-114340400	Bivalent Enhancer	Brain Cingulate Gyrus	brain
45	chr2:114340200-114340400	Enhancers	Brain Substantia Nigra	brain
46	chr2:114340200-114340400	Enhancers	Placenta Amnion	Placenta Amnion
47	chr2:114340200-114340400	Enhancers	Small Intestine	intestine
48	chr2:114340200-114340400	Enhancers	Thymus	Thymus
49	chr2:114340200-114340400	Enhancers	NHEK	skin
50	chr2:114340200-114340400	Enhancers	NHLF	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links